by Mark Chiang

由马克·蒋

Share To

分享到

A biotechnology startup has secured $40 million in funding to advance its development of lab-grown organs, aiming to provide an alternative to animal testing. The company is working on a high-tech platform designed to replicate human organ systems in laboratory settings, potentially offering a more precise and ethical method for drug testing and biomedical research..

一家生物技术初创公司已获得 4000 万美元的资金，用于推进其培养实验室生长器官的开发，旨在为动物实验提供替代方案。该公司正在研发一个高科技平台，旨在实验室环境中复制人体器官系统，有望为药物测试和生物医学研究提供更精确且符合伦理的方法。

The funding comes as federal agencies like the Food and Drug Administration (FDA) and National Institutes of Health (NIH) increasingly move away from reliance on animal testing. The startup’s technology focuses on creating organoids—miniature, simplified versions of human organs grown from stem cells—that can mimic the structure and function of their full-sized counterparts.

这笔资金的投入正值食品和药物管理局 (FDA) 和国立卫生研究院 (NIH) 等联邦机构逐渐减少对动物试验依赖之际。这家初创公司的技术专注于创建类器官——即由干细胞培育出的微型简化版人体器官——这些类器官可以模拟其全尺寸对应器官的结构和功能。

These organoids are intended to serve as models for studying diseases, testing pharmaceuticals, and understanding biological processes without the need for live animal subjects. The $40 million investment will be used to refine this platform and accelerate its application in research settings..

这些类器官旨在作为研究疾病、测试药物和理解生物过程的模型，而无需使用活体动物。4000万美元的投资将用于完善这一平台，并加速其在研究环境中的应用。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: May 29, 2025

日期：2025年5月29日

Related posts:

相关内容：

Swiss Drugmaker Halts Elevidys Trials After Participant’s Death

瑞士制药商在一名参与者死亡后暂停了Elevidys的试验

Pharmacists Can Identify Micronutrient Deficiencies in Type 2 Diabetes Patients, a Population at Elevated Risk.

药剂师可以识别出患有2型糖尿病的患者中的微量营养素缺乏，这一人群的风险较高。

Baptist Health South Florida Integrates Pharmacists into Cardiovascular Care Teams

浸信会健康南佛罗里达将药剂师整合进心血管护理团队

NIH to End Subawards to Foreign Institutions Amid National Security Concerns

美国国立卫生研究院因国家安全担忧将终止对外国机构的子奖项授予

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 保留所有权利。与我们合作：

[email protected]

电子邮件地址

Author

作者

Mark Chiang

马克·江

Related Post

相关内容

News Flash

新闻快讯

New Device Could Streamline CAR T-Cell Therapy Production for Earlier Cancer Treatment

新设备可简化CAR-T细胞疗法生产，促进早期癌症治疗

2025-05-29

2025年5月29日